No changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenyls

Experimental evidence suggests that monoamine oxidase B (MAO-B) and muscarinic cholinergic receptors (mAChRs) are involved in the pathogenesis of neurotoxicity caused by methylmercury and polychlorinated biphenyls (PCBs). Blood samples from 7-year-old exposed children were analyzed for platelet MAO-B and lymphocyte mAChRs as potential markers of exposure to these neurotoxicants. The blood neurotoxicity biomarkers were compared with prenatal and current exposures and with neuropsychological test results. Both biomarkers showed homogeneous distributions within this cohort (mAChR, range 0.04–36.78 fmol/million cells; MAO-B, 0.95–14.95 nmol mg−1 protein h−1). No correlation was found between the two biomarkers and either blood neurotoxicant concentrations or clinical findings. MAO-B and mAChR sensitivity may not be sufficiently high to assess early, subclinical responses to low/moderate methylmercury and/or PCB exposure, whereas these markers are significantly altered in sustained exposure scenarios, as shown by clinical studies in drug addicts or patients treated with psychopharmacological agents.

[1]  S. Ceccatelli,et al.  Human developmental neurotoxicity of methylmercury: impact of variables and risk modifiers. , 2008, Regulatory toxicology and pharmacology : RTP.

[2]  S. Ceccatelli,et al.  Neurodevelopmental toxicity of methylmercury: Laboratory animal data and their contribution to human risk assessment. , 2008, Regulatory toxicology and pharmacology : RTP.

[3]  N. Pivac,et al.  The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  E. Baca-García,et al.  Platelet monoamine oxidase activity in obsessive-compulsive disorder , 2007, European Psychiatry.

[5]  D. Kozaric-Kovacic,et al.  Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder. , 2007, Journal of affective disorders.

[6]  Richard M. Eglen,et al.  Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development , 2007, Nature Reviews Drug Discovery.

[7]  M. Goldoni,et al.  Perinatal co-exposure to methylmercury and PCB153 or PCB126 in rats alters the cerebral cholinergic muscarinic receptors at weaning and puberty. , 2007, Toxicology.

[8]  L. Oreland,et al.  Monoamine oxidases — activities, genotypes and the shaping of behaviour , 2007, Journal of Neural Transmission.

[9]  S. Ceccatelli,et al.  Neurobehavioural and molecular changes induced by methylmercury exposure during development , 2007, Neurotoxicity Research.

[10]  N. Saunders,et al.  Developmental neurotoxicity of industrial chemicals , 2007, The Lancet.

[11]  L. Bierut,et al.  Association of CHRM2 with IQ: Converging Evidence for a Gene Influencing Intelligence , 2007, Behavior genetics.

[12]  A. Castoldi,et al.  Methylmercury interaction with lymphocyte cholinergic muscarinic receptors in developing rats. , 2007, Environmental research.

[13]  D. Posthuma,et al.  Association between the CHRM2 gene and intelligence in a sample of 304 Dutch families , 2006, Genes, Brain and Behavior.

[14]  A. Castoldi,et al.  Brain monoaminergic neurotransmission parameters in weanling rats after perinatal exposure to methylmercury and 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB153) , 2006, Brain Research.

[15]  C. Guatimosim,et al.  Mice Deficient for the Vesicular Acetylcholine Transporter Are Myasthenic and Have Deficits in Object and Social Recognition , 2006, Neuron.

[16]  P. Grandjean,et al.  Effects of developmental co-exposure to methylmercury and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) on cholinergic muscarinic receptors in rat brain. , 2006, Neurotoxicology.

[17]  D. Mergler,et al.  Relationship between platelet monoamine oxidase-B (MAO-B) activity and mercury exposure in fish consumers from the Lake St. Pierre region of Que., Canada. , 2006, Neurotoxicology.

[18]  H. Chan,et al.  Effects of prenatal methylmercury exposure on brain monoamine oxidase activity and neurobehaviour of rats. , 2006, Neurotoxicology and teratology.

[19]  H. Chan,et al.  An interspecies comparison of mercury inhibition on muscarinic acetylcholine receptor binding in the cerebral cortex and cerebellum. , 2005, Toxicology and applied pharmacology.

[20]  P. Baiardi,et al.  Lymphocyte muscarinic receptors and platelet monoamine oxidase-B as biomarkers of CNS function: effects of age and gender in healthy humans. , 2005, Environmental toxicology and pharmacology.

[21]  E. Budtz-Jørgensen,et al.  Umbilical Cord Mercury Concentration as Biomarker of Prenatal Exposure to Methylmercury , 2005, Environmental health perspectives.

[22]  S. Heidemann,et al.  Disruption of intraneuronal divalent cation regulation by methylmercury: are specific targets involved in altered neuronal development and cytotoxicity in methylmercury poisoning? , 2004, Neurotoxicology.

[23]  R. van Reekum,et al.  A review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injury. , 2003, The Journal of neuropsychiatry and clinical neurosciences.

[24]  P. Baiardi,et al.  Platelet monoamine oxidase B activity as a state marker for alcoholism: trend over time during withdrawal and influence of smoking and gender. , 2002, Alcohol and alcoholism.

[25]  L. Snell,et al.  Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labeling, and protein measurements. , 2002, Alcoholism, clinical and experimental research.

[26]  T. Durkin,et al.  Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice , 2002, Behavioural Brain Research.

[27]  L. Parnetti,et al.  Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzheimer's disease: a marker of cholinergic dysfunction? , 2001, Journal of Neuroimmunology.

[28]  J. Shih,et al.  Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B , 2001, Brain Research Bulletin.

[29]  Roberta F. White,et al.  Neurobehavioral deficits associated with PCB in 7-year-old children prenatally exposed to seafood neurotoxicants. , 2001, Neurotoxicology and teratology.

[30]  Y. Kaneda,et al.  Platelet serotonin concentrations in medicated schizophrenic patients , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[31]  D. Rice,et al.  Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. , 2000, Environmental health perspectives.

[32]  E. Budtz-Jørgensen,et al.  Maternal seafood diet, methylmercury exposure, and neonatal neurologic function. , 2000, The Journal of pediatrics.

[33]  E. Hollander,et al.  Decreased platelet monoamine oxidase activity in female bulimia nervosa , 2000, European Neuropsychopharmacology.

[34]  N. Martin,et al.  Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology , 2000, Psychological Medicine.

[35]  L. Prockop,et al.  Low-level exposure to methylmercury modifies muscarinic cholinergic receptor binding characteristics in rat brain and lymphocytes: physiologic implications and new opportunities in biologic monitoring. , 1999, Environmental health perspectives.

[36]  L. Parnetti,et al.  Radioligand binding assay of M1–M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes , 1999, Journal of Neuroimmunology.

[37]  N. Keiding,et al.  Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years. , 1999, American journal of epidemiology.

[38]  J. Hodges,et al.  Attention and executive deficits in Alzheimer's disease. A critical review. , 1999, Brain : a journal of neurology.

[39]  R. Verkes,et al.  Platelet serotonin, monoamine oxidase activity, and [3H]paroxetine binding related to impulsive suicide attempts and borderline personality disorder , 1998, Biological Psychiatry.

[40]  S. Chakrabarti,et al.  Modulation of monoamine oxidase activity in different brain regions and platelets following exposure of rats to methylmercury. , 1998, Neurotoxicology and teratology.

[41]  Roberta F. White,et al.  Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. , 1997, Neurotoxicology and teratology.

[42]  J. Jacobson,et al.  Teratogen update: polychlorinated biphenyls. , 1997, Teratology.

[43]  R. Minoda,et al.  Muscarinic acetylcholine receptors on human lymphocytes in patients with Menière's disease. , 1996, Acta oto-laryngologica.

[44]  D. Ray,et al.  Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. , 1996, Human & experimental toxicology.

[45]  M. Schuckit,et al.  Platelet monoamine oxidase activity levels in subgroups of alcoholics: Diagnostic, temporal, and clinical correlates , 1995, Biological Psychiatry.

[46]  P. Rodier,et al.  Vulnerable periods and processes during central nervous system development. , 1994, Environmental health perspectives.

[47]  J. Richardson,et al.  Chronic L-deprenyl or L-amphetamine: Equal cognitive enhancement, unequal MAO inhibition , 1994, Pharmacology Biochemistry and Behavior.

[48]  J. Shih,et al.  The Deduced Amino Acid Sequences of Human Platelet and Frontal Cortex Monoamine Oxidase B Are Identical , 1993, Journal of neurochemistry.

[49]  Yukun Yuan,et al.  Disruption by methylmercury of membrane excitability and synaptic transmission of CA1 neurons in hippocampal slices of the rat. , 1993, Toxicology and applied pharmacology.

[50]  L. Costa,et al.  Modulation of muscarinic receptors and acetylcholinesterase activity in lymphocytes and in brain areas following repeated organophosphate exposure in rats. , 1993, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[51]  W. Bradshaw,et al.  Effect of PCB and DES on rat monoamine oxidase, acetylcholinesterase, testosterone, and estradiol ontogeny , 1992, Bulletin of environmental contamination and toxicology.

[52]  A. Korczyn,et al.  Decreased (3H) quinuclidinyl benzilate binding to lymphocytes in Gilles de la Tourette syndrome , 1992, Biological Psychiatry.

[53]  J. Rabey,et al.  Changes of muscarinic cholinergic binding by lymphocytes in parkinson's disease with and without dementia , 1991, Annals of neurology.

[54]  J. Nurnberger,et al.  Platelet MAO in subtypes of alcoholism , 1990, Biological Psychiatry.

[55]  P. Riederer,et al.  Platelet MAO‐B activity and the psychopathology of Parkinson's disease, senile dementia and multi‐infarct dementia , 1988, Acta psychiatrica Scandinavica.

[56]  H. Meltzer,et al.  Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: Sex and race interactions , 1987, Psychiatry Research.

[57]  K. Tipton,et al.  Human platelet monoamine oxidase—A useful enzyme in the study of psychiatric disorders? , 1982, Neuroscience.

[58]  M. Reveley,et al.  Human platelet monoamine oxidase activity in health and disease: a review. , 1981, Journal of clinical pathology.

[59]  D. Murphy,et al.  Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase. , 1977, Biochemical pharmacology.

[60]  D. Murphy,et al.  Reduced Monoamine Oxidase Activity in Platelets: A Possible Genetic Marker for Vulnerability to Schizophrenia , 1973, Science.

[61]  D. Murphy,et al.  Reduced Monoamine Oxidase Activity in Blood Platelets from Schizophrenic Patients , 1972, Nature.

[62]  C. Fahlke,et al.  Platelet monoamine oxidase B (MAO-B) activity and its relationship to DL-fenfluramine-induced prolactin response in healthy men , 2005, Journal of Neural Transmission.

[63]  P. Riederer,et al.  Monoamine oxidase-B inhibition in Alzheimer's disease. , 2004, Neurotoxicology.

[64]  P. Stewart,et al.  Cognitive development in preschool children prenatally exposed to PCBs and MeHg. , 2003, Neurotoxicology and teratology.

[65]  L. Prockop,et al.  Assessing effects of neurotoxic pollutants by biochemical markers. , 2001, Environmental research.

[66]  C. Blanco,et al.  Pathological gambling and platelet MAO activity: a psychobiological study. , 1996, The American journal of psychiatry.

[67]  L. Costa,et al.  Interaction of mercury compounds with muscarinic receptor subtypes in the rat brain. , 1996, Neurotoxicology.

[68]  H. Checkoway,et al.  Platelet monoamine oxidase B activity in workers exposed to styrene , 1994, International archives of occupational and environmental health.

[69]  P. Eriksson,et al.  Neonatal exposure to 3,3',4,4'-tetrachlorobiphenyl: changes in spontaneous behaviour and cholinergic muscarinic receptors in the adult mouse. , 1991, Toxicology.

[70]  S. D. Murphy,et al.  In vitro and in vivo modulation of cholinergic muscarinic receptors in rat lymphocytes and brain by cholinergic agents. , 1990, International journal of immunopharmacology.